Anna Liner
Impact in
-
- Cardiovascular Function and Risk Factors
- Cardiac Valve Diseases and Treatments
- Cardiac Fibrosis and Remodeling
- Cardiomyopathy and Myosin Studies
-
- Venous Thromboembolism Diagnosis and Management
Papers in
-
- Cardiovascular Function and Risk Factors 2
- Cardiomyopathy and Myosin Studies 1
- Cardiac Fibrosis and Remodeling 1
-
- Signaling Pathways in Disease 1
- Congenital heart defects research 1
- Co-authors
- Brian D. Hoit (4 shared papers)Keith Fox (1 shared paper)Mark Schluchter (1 shared paper)Michel G. Farah (1 shared paper)Mark A. Smith (2 shared papers)Julie A. Wolfram (2 shared papers)Hyoung‐gon Lee (2 shared papers)Xiongwei Zhu (2 shared papers)
- Journals
- PLoS ONE (1 paper)Journal of the American Society of Echocardiography (1 paper)Circulation Cardiovascular Imaging (1 paper)PubMed (1 paper)
- Partner nations
- United States
In The Last Decade
Anna Liner
4 papers receiving 394 citations
Peers
Comparison fields: 5 of 35
- Cardiology and Cardiovascular Medicine 275
- Internal Medicine 21
- Critical Care and Intensive Care Medicine 17
- Pulmonary and Respiratory Medicine 80
- Epidemiology 50
Countries citing papers authored by Anna Liner
This map shows the geographic impact of Anna Liner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Liner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Liner more than expected).
Fields of papers citing papers by Anna Liner
This network shows the impact of papers produced by Anna Liner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Liner. The network helps show where Anna Liner may publish in the future.
Co-authors
The 20 scholars most cited alongside Anna Liner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 343 | |
| 2 | 2009 | 42 | |
| 3 | 2012 | 18 | |
| 4 | The role of E2F1 in the development of hypertrophic cardiomyopathy. | 2011 | 9 |
About Anna Liner
Anna Liner is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology, Nuclear Energy and Engineering, Waste Management and Disposal and Infectious Diseases, having authored 4 papers that have together received 412 indexed citations. Recurring topics across this work include Cardiovascular Function and Risk Factors (2 papers), Signaling Pathways in Disease (1 paper), Cardiomyopathy and Myosin Studies (1 paper), Cardiac Fibrosis and Remodeling (1 paper) and Congenital heart defects research (1 paper). The work is most often cited by research in Cardiology and Cardiovascular Medicine (275 citations), Internal Medicine (21 citations), Critical Care and Intensive Care Medicine (17 citations), Pulmonary and Respiratory Medicine (80 citations) and Epidemiology (50 citations). Anna Liner has collaborated with scholars based in United States. Frequent co-authors include Brian D. Hoit, Keith Fox, Mark Schluchter, Michel G. Farah, Mark A. Smith, Julie A. Wolfram, Hyoung‐gon Lee, Xiongwei Zhu, Julian E. Stelzer and Sandra L. Siedlak. Their work appears in journals such as PLoS ONE, Journal of the American Society of Echocardiography, Circulation Cardiovascular Imaging and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.